Bicycle Therapeutics PLC Sustainability Reports
Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company that develops a novel class of medicines called Bicycles, which are chemically synthesized constrained bicyclic peptides. These molecules are designed to selectively deliver therapeutic payloads, such as toxins or radioactive isotopes, directly to tumors while minimizing impact on healthy tissues.
Sector: Professional & technical services
Country: United Kingdom
Exchange: Nasdaq
LEI: 213800XKUI6R7GKC3E43
FIGI: BBG00P0YWQ97
5 reports from 2019 to 2024
- Bicycle Therapeutics PLC 2024 Annual Report and Financial Statements
- Bicycle Therapeutics PLC 2023 Annual Report and Financial Statements
- Bicycle Therapeutics PLC 2022 Annual Report and Financial Statements
- Bicycle Therapeutics PLC 2020 Annual Report and Financial Statements
- Bicycle Therapeutics PLC 2019 Annual Report and Financial Statements